InvestorsHub Logo
Followers 61
Posts 3376
Boards Moderated 1
Alias Born 12/26/2012

Re: None

Saturday, 02/02/2013 2:16:51 PM

Saturday, February 02, 2013 2:16:51 PM

Post# of 130503
The Company believes the data are positive, even without statistical significance due to small groups of animals in the densitometry and chemistry data, because there are consistent internal results correlating behavior, stereology, densitometry and neurochemistry, most notably at MANF = 10 ug and GDNF = 10 ug. The Company is preparing to initiate IND enabling studies for MANF as a disease-modifying drug candidate for Parkinson's disease.


http://finance.yahoo.com/news/amarantus-bioscience-announces-positive-efficacy-133100600.html